Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to assess the change in dopamine transporter density in
Parkinson's disease subjects during a sixty month period including a nine month treatment
trial of levodopa. Dopamine transporter will be assessed using [123I]ß-CIT SPECT (single
photon emission computed tomography) imaging, a marker of dopamine terminal integrity and of
clinical disease state.